13
4
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T64200 | C5aR-IN-2 | ||
C5aR-IN-2 is a potent inhibitor of C5aR. C5aR-IN-2 has shown potential for the study of inflammatory diseases. | |||
T73262 | C5aR-IN-3 | ||
C5aR-IN-3, a potent C5aR inhibitor, holds potential for inflammation disease research due to its ability to counteract increased C5a levels, which are linked to autoimmune and inflammatory disorders. | |||
T73261 | C5aR-IN-1 | ||
C5aR-IN-1, a potent inhibitor of C5aR, is linked with the potential to research inflammatory diseases. This association is due to the elevated levels of C5a, which are connected with autoimmune and inflammatory disorders... | |||
T82797 | C5aR1 antagonist peptide | ||
C5aR1 antagonist peptide, a biologically active linear peptide originating from the C-terminus of the chemokine complement fragment 5 anaphylatoxin (C5a), inhibits C5a binding and activity at human and rat C5a receptors.... | |||
T12506L1 | PMX 205 acetate(514814-49-4 free base) | Complement System | |
PMX 205 acetate is an antagonist of complement C5a receptor (C5aR; CD88). | |||
T8223 | Avacopan | CCX168 | Complement System |
Avacopan (CCX168) is an orally administered small-molecule C5aR ( IC50 : 0.1 nM.)antagonist that blocks the effects of C5a and prevents the development of GN induced by anti-myeloperoxidase antibodies in a murine model o... | |||
TP2334 | PMX 53 acetate(219639-75-5 free base) | Complement System | |
PMX-53 is a potent and orally active CD88 (C5aR) antagonist (IC50: 20 nM) and inhibits C5a-induced neutrophil myeloperoxidase release and chemotaxis with IC50 values of 22 nM and 75 nM, respectively. PMX-53 is also an ag... | |||
TP1305L | LEP(116-130)(mouse)TFA(258276-95-8 free base) | Complement System | |
LEP(116-130)(mouse) is a synthetic leptin peptide fragment. | |||
T24524 | NDT 9513727 | NDT9513727,NDT-9513727 | Complement System |
NDT 9513727 is a potent, selective and competitive C5aR1 inverse agonist for the study of inflammatory and immune disorders. | |||
T73710 | PMX 205 Trifluoroacetate | ||
PMX 205 Trifluoroacetate is a potent complement C5a receptor ( C5aR ; CD88 ) antagonist. | |||
T28429 | PMX-53 | PMX53,PMX 53 | |
PMX-53 is a Mas-related gene 2 (MrgX2) agonist and C5aR(CD88) antagonist. PMX-53 reduces atherosclerotic lesions in a mouse model of atherosclerosis, inhibits lung metastasis in a mouse breast cancer model, inhibits C5a-... | |||
T35836 | PMX-205 (trifluoroacetate salt) | ||
PMX-205 is a cyclic hexapeptide that acts as a potent antagonist of C5a receptor (C5aR; IC50= 31 nM).1It is orally active and blocks inflammatory signaling and symptoms in animal models of colitis and allergic asthma.2,3... | |||
T17250 | W-54011 | ROS , Complement System | |
W-54011 is a potent non-peptide C5a receptor antagonist. W-54011 inhibits the binding of 125I-labeled C5a to human neutrophils (Ki: 2.2 nM). W-54011 inhibits C5a-induced intracellular Ca2+ mobilization, chemotaxis, and g... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-01022 | C5AR1 Protein-VLP, Human, Recombinant (His) | Human | HEK293 Cells |
Receptor for the chemotactic and inflammatory peptide anaphylatoxin C5a. The ligand interacts with at least two sites on the receptor: a high-affinity site on the extracellular N-terminus, and a second site in the transm... | |||
TMPH-01023 | C5AR1 Protein, Human, Recombinant (Cell-Free, His) | Human | E. coli |
Receptor for the chemotactic and inflammatory peptide anaphylatoxin C5a. The ligand interacts with at least two sites on the receptor: a high-affinity site on the extracellular N-terminus, and a second site in the transm... | |||
TMPH-03529 | Chemotaxis inhibitory Protein, S. aureus (strain MRSA252), Recombinant (His) | Staphylococcus aureus | P. pastoris (Yeast) |
Involved in countering the first line of host defense mechanisms. Specifically inhibits the response of human neutrophils and monocytes to complement anaphylatoxin C5a and formylated peptides, like N-formyl-methionyl-leu... | |||
TMPH-03528 | Chemotaxis inhibitory Protein, S. aureus (strain NCTC 8325/PS47), Recombinant (His & Myc) | Staphylococcus aureus | E. coli |
Involved in countering the first line of host defense mechanisms. Specifically inhibits the response of human neutrophils and monocytes to complement anaphylatoxin C5a and formylated peptides, like N-formyl-methionyl-leu... |